AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Phase2 Labs Data, Technology Stack, and Enterprise Applications
ERP Services and Operations
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
CliniSys Legacy CliniSys ApolloLIMS Laboratory Management ERP Services and Operations n/a 2020 2020
In 2020, Phase2 Labs implemented CliniSys ApolloLIMS for Laboratory Management to stand up high-throughput molecular COVID-19 testing and to support broader clinical and molecular workflows. The Nashville laboratory completed configuration and go-live in under four weeks, executing a rapid deployment to meet regional public health testing demand. The implementation focused on operational readiness for increased throughput and integrated clinical reporting. The CliniSys ApolloLIMS configuration included instrument interfaces, state reporting workflows, and a patient and provider portal, with the Laboratory Management configuration capturing molecular assay data, sample tracking, and electronic result distribution. Instrument interfaces enabled automated data ingest from high-throughput molecular instruments and linked analytic results into the LIMS test lifecycle. The patient and provider portal provided a conduit for result access alongside the state reporting pipeline. Operational coverage extended across laboratory operations, clinical reporting, and patient and provider communications within the US public health and clinical region served by Phase2 Labs. Governance adjustments centered on standardized test result workflows and automated reporting pipelines to ensure consistent submission to state authorities and streamlined internal turnaround processes. Outcomes documented by Phase2 Labs included automated reporting, faster turnaround, and increased testing capacity.
AI Development
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Perplexity Legacy Perplexity Generative AI Platforms AI Development n/a 2024 2024
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2020 2020
Collaboration Collaboration 2020 2020
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Web Content Management Content Management 2020 2020
ITSM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Performance Management ITSM 2023 2023
PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Apps Development PaaS 2021 2021
Transactional Email PaaS 2021 2021
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2020 2020
Domain Name System (DNS) IaaS 2020 2020
Domain Name System (DNS) IaaS 2021 2021
Domain Name System (DNS) IaaS 2023 2023
CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Secure Email Gateways (SEGs), Archive as a Service (AaaS) CyberSecurity 2021 2021
IT Decision Makers and Key Stakeholders at Phase2 Labs
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Phase2 Labs Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Phase2 Labs Technographics

Phase2 Labs is a Healthcare organization based in United States, with around 22 employees and annual revenues of $5.0 million.

Phase2 Labs operates a diverse technology stack with applications such as CliniSys ApolloLIMS, Perplexity and Microsoft 365, covering areas like Laboratory Management, Generative AI Platforms and Collaboration.

Phase2 Labs has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as CliniSys, Perplexity and Microsoft.

Phase2 Labs recently adopted applications including Perplexity in 2024, Sentry in 2023 and Cloudflare DNS in 2023, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Phase2 Labs’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Phase2 Labs’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Phase2 Labs technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.